Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Total Synthesis of the Glycoside Antibiotic Paulomycin A.

Journal of the American Chemical Society·2026

Same author

Oncometabolite 5-IP<sub>7</sub> inhibits inositol 5-phosphatase to license E-cadherin endocytosis.

Nature chemical biology·2025

Same author

AI-Designed Molecules in Drug Discovery, Structural Novelty Evaluation, and Implications.

Journal of chemical information and modeling·2025

Same author

Do-It-Yourself De Novo Antibody Sequencing Workflow that Achieves Complete Accuracy of the Variable Regions.

Journal of proteome research·2025

Same author

Structure-Based Optimization of TBK1 Inhibitors.

ACS medicinal chemistry letters·2025

Same author

The need to implement FAIR principles in biomolecular simulations.

Nature methods·2025

Search research articles

Related Experiment Video

Updated: Aug 22, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Systematic Investigation of Docking Failures in Large-Scale Structure-Based Virtual Screening.

Min Xu^1,2, Cheng Shen^2,3, Jincai Yang²

¹College of Life Sciences, Beijing Normal University, No. 19 Xinjiekouwai Street, Beijing 100875, China.

|November 7, 2022

Summary

This study compares two molecular docking programs, UCSF DOCK 3.7 and AutoDock Vina, for drug discovery. DOCK 3.7 showed better early enrichment and computational efficiency, though both had limitations in predicting binding poses.

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Aug 22, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

Computational chemistry
Molecular modeling
Drug discovery

Background:

Structure-based virtual screening is crucial for identifying novel drug candidates.
Understanding the performance of docking algorithms is essential for successful virtual screening.
UCSF DOCK 3.7 and AutoDock Vina are widely used docking programs.

Purpose of the Study:

To systematically evaluate the strengths and weaknesses of UCSF DOCK 3.7 and AutoDock Vina.
To identify reasons for docking failures and propose solutions for improved accuracy.
To provide practical guidance for large-scale virtual screening campaigns.

Main Methods:

Comparative analysis of UCSF DOCK 3.7 and AutoDock Vina performance.
Utilized the Directory of Useful Decoys: Enhanced (DUD-E) dataset for evaluation.
Investigated docking successes and failures across six representative cases.

Main Results:

DOCK 3.7 demonstrated superior early enrichment and computational efficiency compared to AutoDock Vina.
Both programs exhibited comparable overall enrichment performance on the DUD-E dataset.
AutoDock Vina's scoring function showed a bias towards higher molecular weight compounds.
Torsion sampling limitations led to inaccuracies in predicted ligand binding poses for both methods.

Conclusions:

DOCK 3.7 offers advantages in computational efficiency and early enrichment for virtual screening.
Ligand binding pose prediction accuracy is limited by torsion sampling in current docking algorithms.
Addressing identified limitations can enhance the success rate of virtual screening and guide future algorithm development.